The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
920165111 9201651 11 F 20120517 20150508 20130401 20160826 EXP PHHY2013JP031003 NOVARTIS TAMARU S, MIZUNO T, SAWAKI A, NAGAHARU K, SAKAGUCHI H, ODA H ET AL.,. SUCCESSFUL TREATMENT IN A PATIENT WITH NEUROENDOCRINE TUMOR WHO DEVELOPED EVEROLIMUS-ASSOCIATED INTERSTITIAL PNEUMONIA. ANNALS OF ONCOLOGY. 2014;25:V104-V105 54.24 YR F Y 54.00000 KG 20160826 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
920165111 9201651 1 PS AFINITOR EVEROLIMUS 1 Oral 10 MG, QD 4865 MG 22334 10 MG TABLET QD
920165111 9201651 2 SS AFINITOR EVEROLIMUS 1 Oral 5 MG, QD 4865 MG 22334 5 MG TABLET QD
920165111 9201651 3 SS AFINITOR EVEROLIMUS 1 Oral 10 MG, QD 4865 MG 22334 10 MG TABLET QD
920165111 9201651 4 SS AFINITOR EVEROLIMUS 1 Oral 10 MG, QD 4865 MG 22334 10 MG TABLET QD
920165111 9201651 5 SS AVAPRO IRBESARTAN 1 Oral 100 MG, UNK 0 100 MG
920165111 9201651 6 C OXYCONTIN OXYCODONE HYDROCHLORIDE 1 Oral 15 MG, UNK Y 0 15 MG
920165111 9201651 7 C OXYCONTIN OXYCODONE HYDROCHLORIDE 1 Oral 20 MG, UNK Y 0 20 MG
920165111 9201651 8 C OXYCONTIN OXYCODONE HYDROCHLORIDE 1 Oral 30 MG, UNK Y 0 30 MG
920165111 9201651 9 C OXYCONTIN OXYCODONE HYDROCHLORIDE 1 Oral 45 MG, UNK Y 0 45 MG
920165111 9201651 10 C OXYCONTIN OXYCODONE HYDROCHLORIDE 1 Oral 30 MG, UNK Y 0 30 MG
920165111 9201651 11 C SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular 30 MG, UNK 0 30 MG INJECTION
920165111 9201651 12 C TAKEPRON LANSOPRAZOLE 1 Oral 15 MG, UNK 0 15 MG TABLET
920165111 9201651 13 C MUCOSTA REBAMIPIDE 1 Oral 300 MG, UNK Y 0 300 MG
920165111 9201651 14 C MAGMITT MAGNESIUM OXIDE 1 Oral 990 MG, UNK 0 990 MG
920165111 9201651 15 C GASMOTIN MOSAPRIDE CITRATE 1 Oral 15 MG, UNK 0 15 MG
920165111 9201651 16 C NAIXAN NAPROXEN SODIUM 1 Oral 600 MG, UNK 0 600 MG
920165111 9201651 17 C FORSENID SENNOSIDES A AND B 1 Oral 24 MG, UNK 0 24 MG
920165111 9201651 18 C FERROUS FUMARATE FERROUS FUMARATE 1 Oral 1 DF, UNK Y 0 1 DF CAPSULE
920165111 9201651 19 C FERROUS FUMARATE FERROUS FUMARATE 1 Oral 1 DF, UNK Y 0 1 DF CAPSULE
920165111 9201651 20 C FERROUS FUMARATE FERROUS FUMARATE 1 Oral 1 DF, UNK Y 0 1 DF CAPSULE
920165111 9201651 21 C SODIUM GUALENATE HYDRATE SODIUM GUALENATE MONOHYDRATE 1 Oropharingeal 5 ML, UNK 0 5 ML MOUTHWASH
920165111 9201651 22 C OXINORM//OXYCODONE HYDROCHLORIDE OXYCODONE HYDROCHLORIDE 1 Oral 5 MG, UNK 0 5 MG
920165111 9201651 23 C OXINORM//OXYCODONE HYDROCHLORIDE OXYCODONE HYDROCHLORIDE 1 Oral 10 MG, UNK 0 10 MG
920165111 9201651 24 C MYSLEE ZOLPIDEM TARTRATE 1 Oral 5 MG, UNK Y 0 5 MG
920165111 9201651 25 C MYSLEE ZOLPIDEM TARTRATE 1 Oral 5 MG, UNK Y 0 5 MG
920165111 9201651 26 C LUNESTA ESZOPICLONE 1 Oral 2 MG, UNK Y 0 2 MG
920165111 9201651 27 C NOVAMIN//PROCHLORPERAZINE MALEATE 2 Oral 5 MG, UNK Y 0 5 MG TABLET
920165111 9201651 28 C NAUZELIN DOMPERIDONE 1 Oral 60 MG, UNK Y 0 60 MG SUPPOSITORY
920165111 9201651 29 C PRIMPERAN METOCLOPRAMIDE HYDROCHLORIDE 1 Oral 5 MG, UNK Y 0 5 MG
920165111 9201651 30 C NORVASC AMLODIPINE BESYLATE 1 Oral 5 MG, UNK 0 5 MG TABLET
920165111 9201651 31 C SANDOSTATIN OCTREOTIDE ACETATE 1 Subcutaneous UNK U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
920165111 9201651 1 Pancreatic neuroendocrine tumour
920165111 9201651 5 Product used for unknown indication
920165111 9201651 6 Product used for unknown indication
920165111 9201651 11 Pancreatic neuroendocrine tumour
920165111 9201651 12 Product used for unknown indication
920165111 9201651 13 Product used for unknown indication
920165111 9201651 14 Product used for unknown indication
920165111 9201651 15 Product used for unknown indication
920165111 9201651 16 Product used for unknown indication
920165111 9201651 17 Product used for unknown indication
920165111 9201651 18 Product used for unknown indication
920165111 9201651 21 Prophylaxis
920165111 9201651 22 Product used for unknown indication
920165111 9201651 24 Product used for unknown indication
920165111 9201651 26 Insomnia
920165111 9201651 27 Prophylaxis
920165111 9201651 28 Prophylaxis
920165111 9201651 29 Prophylaxis
920165111 9201651 30 Product used for unknown indication
920165111 9201651 31 Pancreatic neuroendocrine tumour

Outcome of event

Event ID CASEID OUTC COD
920165111 9201651 OT
920165111 9201651 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
920165111 9201651 Alanine aminotransferase increased
920165111 9201651 Aspartate aminotransferase increased
920165111 9201651 Back pain
920165111 9201651 Blood alkaline phosphatase increased
920165111 9201651 Blood cholesterol increased
920165111 9201651 Blood glucose increased
920165111 9201651 Blood lactate dehydrogenase increased
920165111 9201651 Blood triglycerides increased
920165111 9201651 Cancer pain
920165111 9201651 Gamma-glutamyltransferase increased
920165111 9201651 Gingivitis
920165111 9201651 Hot flush
920165111 9201651 Hyperphosphatasaemia
920165111 9201651 Hyperproteinaemia
920165111 9201651 Hypertension
920165111 9201651 Hypertriglyceridaemia
920165111 9201651 Insomnia
920165111 9201651 Interstitial lung disease
920165111 9201651 Intestinal obstruction
920165111 9201651 Iron deficiency anaemia
920165111 9201651 Malignant neoplasm progression
920165111 9201651 Nausea
920165111 9201651 Palpitations
920165111 9201651 Pharyngitis
920165111 9201651 Stomatitis
920165111 9201651 Subcutaneous abscess

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
920165111 9201651 1 20120515 20130228 0
920165111 9201651 2 20130322 20130517 0
920165111 9201651 3 20130518 20131101 0
920165111 9201651 4 20131106 0
920165111 9201651 6 20130207 0
920165111 9201651 7 20130208 20130321 0
920165111 9201651 8 20130322 20130627 0
920165111 9201651 9 20130628 20130711 0
920165111 9201651 10 20130712 20131101 0
920165111 9201651 11 20130802 0
920165111 9201651 13 20131101 0
920165111 9201651 19 20130405 0
920165111 9201651 20 20140314 20140508 0
920165111 9201651 22 20120131 0
920165111 9201651 23 20140314 0
920165111 9201651 24 20130301 20130308 0
920165111 9201651 25 20131113 0
920165111 9201651 26 20130322 20130712 0
920165111 9201651 27 20130302 20130607 0
920165111 9201651 28 20130322 20130802 0
920165111 9201651 29 20130802 20131101 0
920165111 9201651 30 20140214 0

Execution Time: 0.0055520534515381 seconds (ucode:5211965). Developed by: James D. Barger

 


another James Barger innovation
All original content on this site is © 2013-2024 James D. Barger and SafetyRates.com.